Review The Emerging Profile of Cross-Resistance among the Nonnucleoside HIV-1 Reverse Transcriptase Inhibitors

Bibliographic Details
Title: Review The Emerging Profile of Cross-Resistance among the Nonnucleoside HIV-1 Reverse Transcriptase Inhibitors
Authors: Nicolas Sluis-Cremer
Source: Viruses, Vol 6, Iss 8, Pp 2960-2973 (2014)
Publisher Information: MDPI AG, 2014.
Publication Year: 2014
Collection: LCC:Microbiology
Subject Terms: HIV, reverse transcriptase, nonnucleoside inhibitors, nevirapine, efavirenz, rilpivirine, etravirine, dapivirine, MIV-150, Microbiology, QR1-502
More Details: Nonnucleoside reverse transcriptase inhibitors (NNRTIs) are widely used to treat HIV-1-infected individuals; indeed most first-line antiretroviral therapies typically include one NNRTI in combination with two nucleoside analogs. In 2008, the next-generation NNRTI etravirine was approved for the treatment of HIV-infected antiretroviral therapy-experienced individuals, including those with prior NNRTI exposure. NNRTIs are also increasingly being included in strategies to prevent HIV-1 infection. For example: (1) nevirapine is used to prevent mother-to-child transmission; (2) the ASPIRE (MTN 020) study will test whether a vaginal ring containing dapivirine can prevent HIV-1 infection in women; (3) a microbicide gel formulation containing the urea-PETT derivative MIV-150 is in a phase I study to evaluate safety, pharmacokinetics, pharmacodynamics and acceptability; and (4) a long acting rilpivirine formulation is under-development for pre-exposure prophylaxis. Given their widespread use, particularly in resource-limited settings, as well as their low genetic barriers to resistance, there are concerns about overlapping resistance between the different NNRTIs. Consequently, a better understanding of the resistance and cross-resistance profiles among the NNRTI class is important for predicting response to treatment, and surveillance of transmitted drug-resistance.
Document Type: article
File Description: electronic resource
Language: English
ISSN: 1999-4915
Relation: http://www.mdpi.com/1999-4915/6/8/2960; https://doaj.org/toc/1999-4915
DOI: 10.3390/v6082960
Access URL: https://doaj.org/article/294a66db67b5403b8ab48bc7a1ea5686
Accession Number: edsdoj.294a66db67b5403b8ab48bc7a1ea5686
Database: Directory of Open Access Journals
More Details
ISSN:19994915
DOI:10.3390/v6082960
Published in:Viruses
Language:English